Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ADCT | Adc Therapeutics SA

Healthcare | Biotechnology | Switzerland | NYSE

Index	-	P/E	-	EPS (ttm)	-2.26	Insider Own	33.91%	Shs Outstand	80.64M	Perf Week	24.60%
Market Cap	72.33M	Forward P/E	-	EPS next Y	-2.02	Insider Trans	0.00%	Shs Float	53.30M	Perf Month	-25.25%
Income	-181.31M	PEG	-	EPS next Q	-0.61	Inst Own	55.24%	Short Float / Ratio	9.62% / 10.69	Perf Quarter	-58.28%
Sales	184.39M	P/S	0.39	EPS this Y	-23.33%	Inst Trans	5.52%	Short Interest	5.13M	Perf Half Y	-54.47%
Book/sh	-0.11	P/B	-	EPS next Y	17.52%	ROA	-35.28%	Target Price	8.17	Perf Year	-82.38%
Cash/sh	4.31	P/C	0.21	EPS next 5Y	15.80%	ROE	-339.66%	52W Range	0.68 - 5.75	Perf YTD	-76.64%
Dividend	-	P/FCF	-	EPS past 5Y	85.26%	ROI	-182.17%	52W High	-84.40%	Beta	1.11
Dividend %	-	Quick Ratio	4.88	Sales past 5Y	97.48%	Gross Margin	95.52%	52W Low	31.72%	ATR	0.10
Employees	317	Current Ratio	5.12	Sales Q/Q	11.52%	Oper. Margin	-58.01%	RSI (14)	41.97	Volatility	17.86% 10.99%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	30.91%	Profit Margin	-98.33%	Rel Volume	0.57	Prev Close	0.83
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 08 BMO	Payout	-	Avg Volume	479.45K	Price	0.90
Recom	2.00	SMA20	-3.67%	SMA50	-26.35%	SMA200	-63.96%	Volume	275,233	Change	8.07%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-10-23	Upgrade	JP Morgan	Underweight → Neutral
Apr-24-23	Downgrade	BofA Securities	Neutral → Underperform	$7 → $2
Dec-06-22	Initiated	CapitalOne	Overweight	$12
Nov-09-22	Downgrade	BofA Securities	Buy → Neutral	$14 → $7
Sep-21-22	Initiated	JP Morgan	Overweight	$5
Sep-09-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $11
Nov-09-21	Initiated	Wolfe Research	Outperform	$44
Aug-17-21	Resumed	Jefferies	Buy	$40
Aug-09-21	Initiated	RBC Capital Mkts	Outperform	$33
Jun-15-21	Initiated	Cantor Fitzgerald	Overweight	$13
Dec-03-20	Initiated	Stifel	Hold	$42
Oct-29-20	Initiated	H.C. Wainwright	Buy	$47
Jun-09-20	Initiated	Cowen	Outperform
Jun-09-20	Initiated	BofA/Merrill	Buy	$45

Show Previous Ratings

Sep-05-23 07:00AM	ADC Therapeutics to Participate in September Investor Conferences (GlobeNewswire) -7.38%
Aug-30-23 07:33PM	ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) (GlobeNewswire)
Aug-14-23 10:51AM	Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% (Zacks)
Aug-11-23 10:53AM	Catalyst (CPRX) Q2 Earnings & Sales Top, 2023 Outlook Raised (Zacks)
Aug-10-23 10:31AM	Novo Nordisk (NVO) Q2 Earnings and Sales Miss, 2023 View Up (Zacks) +7.33%
12:09PM	Loading…
Aug-09-23 12:09PM	Horizon (HZNP) Q2 Earnings Top, Krystexxa & Uplizna Boost Sales (Zacks) -6.25%
Aug-08-23 11:01PM	Q2 2023 ADC Therapeutics SA Earnings Call (Thomson Reuters StreetEvents) +11.89%
10:48AM	Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates (Zacks)
08:15AM	ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:00AM	ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-07-23 05:25PM	MannKind (MNKD) Reports Break-Even Earnings for Q2 (Zacks)
Aug-04-23 08:40AM	Intra-Cellular (ITCI) Q2 Earnings & Sales Top, '23 View Raised (Zacks)
08:12AM	Ultragenyx (RARE) Q2 Loss Wider Than Expected, Revenues Beat (Zacks)
Aug-03-23 11:48AM	Corcept (CORT) Beats on Q2 Earnings, Ups '23 Sales View (Zacks)
11:45AM	Editas' (EDIT) Q2 Earnings Beat, Sales Miss, Pipeline in Focus (Zacks)
08:02AM	Loading…
08:02AM	Acadia (ACAD) Q2 Earnings & Revenues Beat Estimates, '23 View Up (Zacks)
Aug-02-23 12:45PM	Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated (Zacks)
12:42PM	Blueprint (BPMC) Q2 Earnings and Revenues Beat Estimates (Zacks)
Aug-01-23 10:45AM	Apellis (APLS) Q2 Earnings Top, Syfovre Sales Boost Revenues (Zacks)
07:22AM	Are Investors Undervaluing ADC Therapeutics SA (NYSE:ADCT) By 27%? (Simply Wall St.)
07:00AM	ADC Therapeutics to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023 (GlobeNewswire)
Jul-28-23 08:02AM	Dr. Reddy's (RDY) Q1 Earnings and Revenues Beat Estimates (Zacks)
Jul-26-23 08:52AM	Bayer (BAYRY) Cuts 2023 Outlook, Reports Preliminary Q2 Results (Zacks)
Jul-24-23 01:20PM	Alnylam (ALNY) to Co-Develop Hypertension Drug With Roche (Zacks) -7.75%
11:12AM	Horizon's (HZNP) Daxdilimab Fails to Meet Goal in Lupus Study (Zacks)
07:21AM	Overland ADCT BioPharma Announces NMPA Accepts Biologics License Application and Grants Priority Review for ZYNLONTA® for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (GlobeNewswire)
Jul-21-23 01:22PM	GSK Gears Up for Q2 Earnings: Will It Surpass Estimates? (Zacks) -5.33%
07:44AM	Astria (ATXS) Rises 5% on Fast Track Tag for Angioedema Drug (Zacks)
Jul-20-23 04:05PM	ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients (GlobeNewswire)
Jul-19-23 09:59AM	Adial (ADIL) Shares Up 43% in the Past Week: Here's Why (Zacks)
11:04AM	Loading…
Jul-18-23 11:04AM	Ligand (LGND) Offers $15M in Cash to Acquire All Novan Assets (Zacks)
Jul-17-23 10:59AM	Theseus (THRX) Falls 72% on Decision to Discontinue GIST Study (Zacks)
10:06AM	Alnylam (ALNY) Posts Upbeat Data From Alzheimer's Disease Study (Zacks)
Jul-14-23 10:56AM	Halozyme (HALO) Rises 5% as Ocrevus SC Meets Goals in MS Study (Zacks)
09:55AM	ADC Therapeutics SA (ADCT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
08:03AM	Acadia (ACAD) Expands Existing Licensing Deal With Neuren (Zacks)
Jul-13-23 09:35AM	After Plunging -34.06% in 4 Weeks, Here's Why the Trend Might Reverse for ADC Therapeutics SA (ADCT) (Zacks)
07:08AM	AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46% (Zacks)
Jul-12-23 10:27AM	ADC Therapeutics (ADCT) Dips on Halting Zynlonta Study (Zacks) -18.38%
Jul-11-23 12:50PM	Panbela (PBLA) Up 11% on Update From Pancreatic Cancer Study (Zacks) -21.94%
10:24AM	Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30% (Zacks)
07:17AM	ADC Therapeutics pauses enrolment in mid-stage trial for cancer therapy (Reuters)
07:00AM	ADC Therapeutics Announces Voluntary Pause of Enrollment in the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients (GlobeNewswire)
Jun-15-23 07:15AM	ADC Therapeutics Announces Evolution of Board of Directors (GlobeNewswire)
Jun-09-23 07:15AM	ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL (GlobeNewswire)
Jun-01-23 07:15AM	ADC Therapeutics to Participate in the Jefferies Healthcare Conference (GlobeNewswire)
May-11-23 12:33PM	ADC Therapeutics Announces Updated Results from LOTIS-2 Trial to be Presented at the European Hematology Association 2023 Hybrid Congress (Business Wire)
06:17AM	These Analysts Think ADC Therapeutics SA's (NYSE:ADCT) Sales Are Under Threat (Simply Wall St.)
May-10-23 07:15AM	ADC Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference (Business Wire) +10.60%
06:09AM	ADC Therapeutics First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.)
May-09-23 08:15AM	ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update (Business Wire)
May-02-23 10:01AM	Xenon Pharmaceuticals (XENE) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
07:15AM	ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023 (Business Wire)
May-01-23 10:01AM	Analysts Estimate ADC Therapeutics SA (ADCT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-17-23 02:53PM	ADC Therapeutics SA (NYSE:ADCT) is definitely on the radar of institutional investors who own 34% of the company (Simply Wall St.) +10.09%
Mar-22-23 03:44AM	Seres Therapeutics (MCRB) Moves 10.9% Higher: Will This Strength Last? (Zacks)
Mar-15-23 03:11PM	ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022 (Business Wire)
Mar-08-23 11:54AM	BioMarin (BMRN) Provides FDA Filing Update for Gene Therapies (Zacks)
Mar-07-23 09:35AM	Down -36.18% in 4 Weeks, Here's Why ADC Therapeutics SA (ADCT) Looks Ripe for a Turnaround (Zacks)
Mar-03-23 11:18AM	ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-01-23 07:15AM	ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference (Business Wire) -6.11%
Feb-28-23 08:35AM	ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -11.55%
07:00AM	ADC Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates (Business Wire)
Feb-21-23 07:15AM	ADC Therapeutics to Host Fourth Quarter and Year-End 2022 Financial Results Conference Call on February 28, 2023 (Business Wire)
Feb-02-23 07:15AM	ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder (Business Wire) -10.09%
Feb-01-23 07:15AM	ADC Therapeutics to Participate in February Investor Conferences (Business Wire) +6.65%
Jan-25-23 10:21AM	Pliant Therapeutics (PLRX) Surges 44% in A Week: Here's Why (Zacks)
Jan-23-23 11:01AM	Amarin Corporation (AMRN) Down 13% in One Week: Here's Why (Zacks)
Jan-16-23 09:55AM	Wall Street Analysts Think ADC Therapeutics SA (ADCT) Could Surge 174.2%: Read This Before Placing a Bet (Zacks)
Jan-13-23 07:28AM	ADC Therapeutics SA (ADCT) Stock Jumps 21.8%: Will It Continue to Soar? (Zacks)
Jan-04-23 07:15AM	ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-03-23 04:30PM	ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer (Business Wire) -6.51%
Dec-21-22 02:00AM	ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (Business Wire)
Dec-19-22 07:15AM	ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer (Business Wire) -6.46%
Dec-12-22 08:00AM	FREENOME PRESENTS RESEARCH HIGHLIGHTING THE PROMISE OF IDENTIFYING DRUG-RESPONSE BIOMARKERS FOR DLBCL PATIENTS (PR Newswire)
Dec-05-22 05:30AM	FDA Takes Tougher Line on Fast-Tracked Drugs (The Wall Street Journal)
Nov-28-22 09:47AM	Biocytogen Enters into Antibody Agreement with ADC Therapeutics (Business Wire) -5.29%
Nov-16-22 07:05AM	The past year for ADC Therapeutics (NYSE:ADCT) investors has not been profitable (Simply Wall St.)
Nov-08-22 08:15AM	ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Nov-07-22 07:15AM	ADC Therapeutics to Participate in the Jefferies London Healthcare Conference (Business Wire)
Nov-04-22 05:46AM	Arcturus Therapeutics (ARCT) Surges 18.7%: Is This an Indication of Further Gains? (Zacks)
Nov-03-22 09:34AM	ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting (Business Wire) +5.81%
Nov-02-22 04:05PM	IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkins Lymphoma (GlobeNewswire) -6.56%
Nov-01-22 07:15AM	ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer (Business Wire)
Oct-31-22 07:15AM	ADC Therapeutics to Host Third Quarter 2022 Financial Results Conference Call on November 8, 2022 (Business Wire)
Oct-26-22 12:46PM	Will AbbVie's Immunology Drugs Continue to Drive Q3 Earnings? (Zacks)
Oct-25-22 01:34PM	Vertex (VRTX) to Report Q3 Earnings: What's in the Cards? (Zacks)
Oct-12-22 09:35AM	Down 27.9% in 4 Weeks, Here's Why You Should You Buy the Dip in ADC Therapeutics SA (ADCT) (Zacks)
Oct-11-22 09:35AM	Down 28.5% in 4 Weeks, Here's Why ADC Therapeutics SA (ADCT) Looks Ripe for a Turnaround (Zacks)
Sep-21-22 07:00PM	ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022) (Business Wire)
Sep-16-22 07:15AM	ADC Therapeutics and Sobi Announce ZYNLONTA® (loncastuximab tesirine) Receives Positive CHMP Opinion in Europe for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (Business Wire)
Sep-06-22 07:15AM	ADC Therapeutics to Participate in Morgan Stanleys 20th Annual Global Healthcare Conference (Business Wire) -6.22%
Aug-15-22 04:30PM	ADC Therapeutics Announces $175 million Senior Secured Term Loan from Owl Rock and Oaktree and Settlement of Existing Senior Secured Convertible Notes (Business Wire) -9.90%
Aug-10-22 12:01AM	ADC Therapeutics SA (ADCT) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 08:25AM	ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:00AM	ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Aug-05-22 04:27AM	Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Beats Revenue Estimates (Revised) (Zacks) +5.60%
Aug-03-22 08:25AM	Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Misses Revenue Estimates (Zacks)

ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADCT | Adc Therapeutics SA

Upgrade your FINVIZ experience